Description
Scope of Abdominal Stent Graft System Market
A bulge in the aorta, a main artery that extends from the heart to the chest and body, is known as an aortic aneurysm. The primary cause of death in humans, aortic dissection or rupture, can be brought on by aortic aneurysms. Abdominal aortic aneurysm is extremely prevalent in males over the age of 65 and occurs below the chest. The most prevalent cause of abdominal aortic aneurysm is atherosclerosis, which produces less symptoms like deep back or side pain or soreness in the buttocks, legs, or groin. Medical devices called stent graft systems are frequently utilized in transcatheter endovascular aortic repair (EVAR) procedures to seal aortic aneurysms.
In terms of revenue, in 2023, the global Abdominal Stent Graft System market was valued at USD 288 Million, with a forecast of USD 392 Million by 2030. From 2023 to 2030, the global Absorbable Tissue Spacer Market is estimated to increase at a compound annual growth rate (CAGR) of 4.30%. The research looks at the market in terms of revenue in all of the key regions, which have been divided into countries.
An analysis of the major market participants, including an examination of their market share, product lines, partnerships, tactics, mergers, and acquisitions. An examination of the drivers behind the market’s expansion, including the growing incidence of abdominal aortic aneurysms (AAA), the aging population, improvements in stent graft technology, and the growing range of minimally invasive procedures. Evaluation of new developments, inventions, and research and development efforts influencing the development of abdominal stent graft systems, encompassing materials science, imaging technologies, and surgical methods.
Impact of COVID – 19
During the peak of the epidemic, many elective procedures—including those using abdominal stent graft systems—were canceled or postponed to prioritize resources for COVID-19 patients. As a result, procedure volumes significantly decreased, which had an impact on market expansion. Movement restrictions, border closures, and production disruptions have created problems for the supply chain, including shortages of components, raw materials, and completed goods. This has impacted the accessibility of systems for abdominal stent grafting and may result in higher expenses.
The pandemic may have limited the use of costly medical technology like abdominal stent graft systems by reducing healthcare expenditures, increasing unemployment, and placing financial strain on healthcare facilities. Notwithstanding the difficulties, the pandemic has encouraged resilience and creativity in the healthcare sector. As healthcare demands and tastes change, manufacturers may look into new technologies to improve the usability and functionality of abdominal stent graft systems, such as enhanced materials or remote monitoring capabilities.
Abdominal Stent Graft System Market: Growth Drivers
-
Increasing Incidence of Abdominal Aortic Aneurysms (AAAs):
The incidence of AAAs is increasing due in part to the rising prevalence of risk factors like smoking, hypertension, and aging populations. This fuels the market expansion for abdominal stent graft systems by creating a demand for them as a minimally invasive therapeutic option for controlling AAAs.
-
Advancements in Minimally Invasive Surgery (MIS) Techniques:
The use of minimally invasive surgical approaches for the treatment of AAAs has been made easier by technological developments in stent graft materials, surgical instruments, and imaging modalities. The market for abdominal stent graft systems is expanding because of its advantages over open operations, which include less surgical trauma, quicker recovery periods, and better patient outcomes.
-
Patient-Centric Care and Outcomes:
Adoption of cutting-edge medical technologies, such as abdominal stent graft systems, is encouraged by a growing emphasis on patient-centric care and better treatment outcomes. Better safety profiles, lower rates of complications, and improved long-term durability are features that appeal to patients and stimulate the market.
-
Extension of Healthcare Infrastructure:
Access to cutting-edge medical therapies, like as endovascular procedures for AAAs, is made easier by improvements in healthcare infrastructure, especially in emerging markets. In these regions, market growth is attributed to factors such as increasing healthcare expenditure, expanding insurance coverage, and increased awareness of treatment choices.
Abdominal Stent Graft System Market: Restraints
-
High Treatment Costs:
Abdominal stent graft systems are frequently associated with high treatment costs, which include the device itself, surgical procedures, hospitalization, and post-operative care. The affordability of these treatments may be an issue for patients, healthcare providers, and payers, especially in areas with low healthcare budgets or reimbursement limits.
-
Limited Reimbursement Coverage:
The reimbursement rules and coverage for abdominal stent graft treatments may range among healthcare systems and regions. Inadequate reimbursement or reimbursement limits may restrict patient access to certain treatments and discourage healthcare professionals from providing them, especially for off-label or exploratory reasons.
-
Procedural Complexity:
Abdominal stent graft operations necessitate particular skills and experience in endovascular surgery, interventional radiology, or vascular surgery. The complexity of these treatments may limit their availability to healthcare centers with experienced operators and extensive infrastructure, especially in rural or underserved areas.
-
Anatomical Challenges:
Patient-specific anatomical variances and complex vascular anatomy in the abdomen area might make it difficult to select, size, and place stent grafts. Inadequate preoperative planning, imaging, or anatomical restrictions may increase the likelihood of procedure problems and poor outcomes.
Abdominal Stent Graft System Market: Opportunity factors
Because of the aging of the world population, elderly people are more likely to have abdominal aortic aneurysms (AAAs). The chance of acquiring AAAs rises with age, which is driving up demand for abdominal stent graft systems designed to treat and control these disorders. Innovation in abdominal stent graft systems is being propelled by ongoing developments in materials science, imaging technology, and minimally invasive surgical approaches. Innovative materials can enhance the functionality, longevity, and patient outcomes of medical devices. Examples of these materials are drug-eluting coatings and bio-resorbable polymers.
Patients’ awareness of and desire for treatment choices are rising as a result of growing knowledge about the dangers of AAAs and the advantages of early diagnosis via screening programs. The market for abdominal stent graft systems is further expanded by public health campaigns and educational programs that support AAA screening and prevention. Abdominal stent graft systems are in high demand due to patients’ growing preference for less invasive surgical treatments, which are associated with faster recovery times, shorter hospital stays, and lower rates of complications. The demand for these gadgets is anticipated to rise as individuals and healthcare professionals choose less intrusive procedures.
Abdominal Stent Graft System Market: Challenges
One major problem is adhering to the strict regulatory criteria for licensing and certification of abdominal stent transplant systems in various areas. Timelines for product development and market entrance can be impacted by the complexity and time required to comply with changing regulations and standards. Developing strong engineering and materials science skills is necessary to create enhanced abdominal stent transplant systems that are safer, more durable, and more effective. Manufacturers face a problem in guaranteeing compatibility with current medical practices and procedures while overcoming technology limitations.
The effective implementation of abdominal stent transplant systems depends on the best possible patient selection and informed consent. However, abdominal aortic aneurysms are complex and patient preferences vary, it can be difficult to identify eligible candidates, educate patients and healthcare professionals about treatment alternatives, and manage expectations. Insufficient availability of cutting-edge medical facilities, particularly in remote and underprivileged regions, may impede the growth of abdominal stent graft systems. To provide equitable access to care and expand market reach, it is imperative to improve the healthcare infrastructure, which includes providing specialized training for healthcare personnel.
Abdominal Stent Graft System Market: Recent Developments
- Medtronic, a leading medical technology business, provides a variety of abdominal stent graft systems, including the Endurant II and Endurant Evo AAA stent grafts. Recent breakthroughs may include improvements in Medtronic’s stent graft designs, delivery methods, and graft materials, which could improve device performance and patient outcomes.
- Cook Medical is a multinational medical device manufacturer that produces abdominal stent graft systems such the Zenith Flex and Zenith Alpha Thoracic stent grafts. Recent innovations may include the introduction of innovative stent graft configurations, delivery catheters, and imaging technologies to improve the procedural success and durability of endovascular repairs.
- Terumo provides abdominal stent graft systems for the treatment of AAA, including the RelayPlus stent graft system. Recent innovations may include the introduction of novel product configurations, delivery catheters, and procedural accessories to enhance the usability and clinical outcomes of Terumo’s stent graft technology.
Abdominal Stent Graft System Market: Key Outcomes of the Report
In Europe, the market is being driven by an aging population, an increase in screening and aortic aneurysm diagnosis, and an increase in demand for endovascular treatment.
Brazil dominates the South American market for Abdominal Stent Graft System. Brazil, with a relatively high healthcare spending in comparison to the rest of the area, provides better healthcare to its people, increasing the likelihood that an aortic aneurysm or dissection would be discovered prior to rupture.
Over the projected period, the Hospital segment from End User is predicted to grow in the abdominal stent graft system market.
List of Key Players in the Global Abdominal Stent Graft System Market:
- Medtronic plc
- Cook Medical LLC
- Endologix, Inc.
- Terumo Corporation
- Lombard Medical Technologies (Acquired by MicroPort Scientific Corporation)
- L. Gore & Associates, Inc.
- Cardinal Health (Cordis Corporation)
- JOTEC GmbH
- MicroPort Scientific Corporation
- Bolton Medical (Acquired by Vascutek Ltd., a Terumo Company)
- Endospan Ltd.
- Lifetech Scientific Corporation
- Gore & Associates
- Merit Medical Systems, Inc.
- Penumbra, Inc.
Abdominal Stent Graft System Market: Segmentation
By Product Type
- Bifurcated Stent Grafts
- Aorto-uni-iliac (AUI) Stent Grafts
- Bifurcated/Branched Stent Grafts
By Material Type
- Metal Stent Grafts
- Polymer-based Stent Grafts
By End Users
- Hospitals
- Ambulatory Surgical Centers
- Specialty Centers.
By Region
- North America
- Europe
- Asia Pacific
